Professor Peter Barnes DM, DSc, FRCP, Master FCCP, FMedSci, FRS, FERS
Peter Barnes is Margaret-Turner Warwick Professor of Medicine at the National Heart and Lung Institute and Honorary Consultant Physician at Royal Brompton Hospital, London. He qualified at Cambridge and Oxford Universities (first class honours) and was appointed to his present post in 1987 and was head of respiratory medicine at Imperial College until 2017. He has published >1200 peer-review papers on asthma, COPD and related topics (h-index 168) and has written or edited over 50 books. He is one of the top 10 most highly cited researchers in the world and the most highly cited respiratory researcher in the world over the last 30 years.
He was elected a Fellow of the Royal Society in 2007, the first respiratory researcher for over 150 years. He is currently a member of the Scientific Committee of global guidelines on COPD (GOLD). He also serves on the Editorial Board of over 30 journals and is currently an Associate Editor of Chest, Journal of COPD Foundation and Editor in Chief of Up-to-Date Pulmonary Diseases. He has given several prestigious lectures, including the Amberson Lecture at the American Thoracic Society, the Sadoul Lecture at the European Respiratory Society and the Croonian Lecture at the Royal College of Physicians. He has been received honorary degrees from the Universities of Ferrara (Italy), Athens (Greece), Tampere (Finland), Leuven (Belgium) and Maastricht (Netherlands). He is an emeritus NIHR Senior Investigator, a Master Fellow of the American College of Chest Physicians and elected member of Academia Europaea and American Association of Physicians. He served as President of the European Respiratory Society 2013/14 and is currently President of the British Association for Lung Research. He co-founded an Imperial spin-out company RespiVert, which was acquired by Johnson & Johnson and has developed novel inhaled treatments for COPD and severe asthma.